How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/skin-and-soft-tissue-infections-due-to-susceptible-streptococci.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Skin and soft-tissue infections due to susceptible streptococci — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Skin and soft-tissue infections due to susceptible streptococci (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Skin and soft-tissue infections due to susceptible streptococci, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Bicillin C-R	Penicillin G Benzathine	Pfizer Inc.	Beta-lactam antibiotic	Cell-wall peptidoglycan biosynthesis

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer Inc. · 1 drug in Skin and soft-tissue infections due to susceptible streptococci

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Skin and soft-tissue infections due to susceptible streptococci:

Cite this brief

Drug Landscape (2026). Skin and soft-tissue infections due to susceptible streptococci — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/skin-and-soft-tissue-infections-due-to-susceptible-streptococci. Accessed 2026-06-10.

Skin and soft-tissue infections due to susceptible streptococci full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing